Nabumetone-d3 is the deuterium-labeled form of Nabumetone (HY-B0559), an orally active, non-acidic anti-inflammatory agent. It acts as a potent and selective COX-2 inhibitor and is a proagent for its active metabolite, α-Demethylnaproxen (HY-W086896). Nabumetone has been observed to inhibit cancer cell proliferation and reduce gastric ulcers. This compound is intended for research applications, such as a tracer or an internal standard in quantitative analyses like NMR, GC-MS, or LC-MS.
- Deuterium-labeled form of nabumetone.
- Orally active, non-acidic anti-inflammatory agent.
- Potent and selective COX-2 inhibitor.
- Proagent for its active metabolite.
- Inhibits cancer cell proliferation.
- Reduces gastric ulcers.
- Intended for research applications.
- Suitable as a tracer or internal standard in quantitative analyses like NMR, GC-MS, or LC-MS.